ORGANIZATION

• JPMA Notifies of Unfavorable Expressions for Disease Awareness Ads
  January 16, 2015

• Pharma Leader Nakayama Hails Tax Plan, Says His New Year Remarks Misleading
  January 15, 2015

• Wholesalers Must Revamp Biz Model to Cope with Change in Sales Mix: JPWA Chief
  January 14, 2015

• Price Grouping Rule Triggered “Distortion” in Generic Market: JGA President
  January 9, 2015

• Pharma Biz Leader Airs Concern over Effective Tax Hikes
  January 8, 2015

• Sumitomo Dainippon President Praises Govt’s Healthcare Measures
  January 6, 2015

• FPMAJ Chairman Wishes for Good Environment for Drug Innovation in 2015
  January 1, 2015

• FPMAJ “Hasn’t Given Up” on Maintenance of 30% R&D Tax Deduction Cap: Chairman
  December 24, 2014

• EFPIA Japan Chairman Calls for More Rewards for Innovation
  December 22, 2014

• Bristol-Myers Reprimanded by JPMA over Misconduct in Sprycel Trial
  December 19, 2014

• JPMA to Formulate Strict Official Policy on Advertising Aimed at Medical Institutions by End of Fiscal Year
  December 19, 2014

• JMA Chief Lauds Big Win by LDP, Komeito in Lower House Race
  December 17, 2014

• JPMA to Require Disclosure of Clinical R&D Costs in More Detail
  December 15, 2014

• JMA, JAMS Call for Enhancing Support for Girls Suffering from Post-HPV Vaccine Reactions
  December 12, 2014

• JPMA President Opposes Annual NHI Price Revision
  November 21, 2014

• PhRMA Chair Prods Japan to Permanently Install Key Pricing Premium
  November 20, 2014

• Ihoken Proposes Revision of Compensation Guidelines to Include Compensation for Injury Due to Anticancer Drugs
  November 20, 2014

• Mr Aoyagi of JPMA Calls for Negotiating Invoice Prices for Individual Products
  November 17, 2014

• No Nippon Pharmacy Association Affiliated Pharmacy Will Be Subject to Medical Fee Cut Rule: Survey
  November 17, 2014

• JPMA, JPPA, and JPWA Express Strong Opposition to Annual NHI Price Revision
  November 4, 2014

ページ

• « 先頭
• ‹ Prev
• …
• 55
• 56
• 57
• 58
• 59
• 60
• 61
• 62
• 63
• …
• Next ›
• 最終 »